About Leica Biosystems
Leica Biosystems is a company based in Nussloch (Germany) founded in 1989 by Helmut Zarbl. It operates as a B2B. Leica Biosystems has completed 5 acquisitions, including Aperio Technologies, Cell IDx and Kreatech. Leica Biosystems offers products and services including Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S. Leica Biosystems operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Nussloch, Germany
- Founders Helmut Zarbl
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leica Biosystems Nussloch Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Aperio Technologies
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leica Biosystems
Leica Biosystems offers a comprehensive portfolio of products and services, including Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S.
Automated scanner for high-capacity digital pathology slide imaging.
Instruments for advanced IHC and ISH staining in cancer diagnostics.
Compact system for slide printing and specimen tracking in labs.
People of Leica Biosystems
Unlock access to complete
Funding Insights of Leica Biosystems
Detailed funding history for Leica Biosystems
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leica Biosystems
Leica Biosystems has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Aperio Technologies, Cell IDx and Kreatech.
Investment portfolio details for Leica Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Immunodiagnostic reagents for immunohistochemistry are manufactured and marketed.
|
Locked | Locked | 2012 | Locked | |
|
Digitized pathology solutions for healthcare providers
|
Locked | Locked | 1999 | Locked | |
|
Novel FISH probes are developed for genetic aberration detection.
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for Leica Biosystems
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Leica Biosystems
Detailed financials for Leica Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leica Biosystems Comparisons
Peer comparison for Leica Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leica Biosystems
Leica Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Leica Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leica Biosystems
Complete news archive for Leica Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leica Biosystems
Leica Biosystems was founded in 1989.
Leica Biosystems is headquartered in Nussloch, Germany. It is registered at Nussloch, Baden-wurttemberg, Germany.
Leica Biosystems specializes in developing and supplying equipment for anatomic pathology workflows, including tissue processors, slide scanners, and IHC instruments. They offer consumables and software to support cancer diagnostics and laboratory operations. Based in Deer Park, Illinois, USA, they serve medical institutions, universities, and healthcare providers globally, ensuring reliable and integrated solutions for pathology challenges.
Leica Biosystems's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Leica Biosystems offers Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S.
Leica Biosystems has made 5 acquisitions, including Aperio Technologies, Cell IDx, and Kreatech.